Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHBP | P24387 | 1/20 | 0.44 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2706290 | 1.00 | CRHBP (0.44) | CRHBPCRHR2MEN1MAPTKMT2A | |
| SCHEMBL15275536 | 0.80 | GABRA1 (0.41) | MAPTKMT2ALMNA | |
| SCHEMBL12786256 | 0.77 | MEN1 (0.44) | CRHBPCRHR2MEN1MAPTKMT2A | |
| SCHEMBL6395417 | 0.76 | — | — | |
| SCHEMBL2850698 | 0.75 | SLC6A2 (0.30) | — | |
| SCHEMBL1315082 | 0.72 | MAPK1 (0.32) | ACHE | |
| SCHEMBL30480018 | 0.72 | MAPK1 (0.32) | ACHE | |
| SCHEMBL4008294 | 0.70 | CA1 (0.37) | LMNA | |
| SCHEMBL2852138 | 0.70 | TAAR1 (0.39) | HTR2ASLC6A4 | |
| SCHEMBL6733419 | 0.68 | MAPT (0.38) | MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025063737-A1 | METHOD FOR PREPARING SUBSTITUTED FUSED IMIDAZOLE DERIVATIVE | YUNOVIA CO., LTD. (KR) | 2025-03-27 | — | — | WO | disclosed |